These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1442 related items for PubMed ID: 18848856

  • 21. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M, Romeijn SG, Verhoef JC, Junginger HE, Bungener L, Huckriede A, Crommelin DJ, Jiskoot W.
    Vaccine; 2007 Jan 02; 25(1):144-53. PubMed ID: 16973248
    [Abstract] [Full Text] [Related]

  • 22. An α-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine.
    Lee YS, Lee KA, Lee JY, Kang MH, Song YC, Baek DJ, Kim S, Kang CY.
    Vaccine; 2011 Jan 10; 29(3):417-25. PubMed ID: 21087689
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations.
    Miyaki C, Quintilio W, Miyaji EN, Botosso VF, Kubrusly FS, Santos FL, Iourtov D, Higashi HG, Raw I.
    Vaccine; 2010 Mar 16; 28(13):2505-9. PubMed ID: 20123051
    [Abstract] [Full Text] [Related]

  • 25. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.
    J Virol; 2005 Oct 16; 79(19):12401-7. PubMed ID: 16160167
    [Abstract] [Full Text] [Related]

  • 26. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.
    Amorij JP, Saluja V, Petersen AH, Hinrichs WL, Huckriede A, Frijlink HW.
    Vaccine; 2007 Dec 17; 25(52):8707-17. PubMed ID: 17996993
    [Abstract] [Full Text] [Related]

  • 27. Protective antibody responses against A(H1N1)pdm09 primed by infection and recalled by intranasal vaccination.
    Ikeda K, Ainai A, Hasegawa H.
    Vaccine; 2015 Nov 09; 33(45):6066-9. PubMed ID: 26432916
    [Abstract] [Full Text] [Related]

  • 28. Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms.
    Chen CY, Liu HJ, Tsai CP, Chung CY, Shih YS, Chang PC, Chiu YT, Hu YC.
    Vaccine; 2010 Nov 10; 28(48):7644-51. PubMed ID: 20883735
    [Abstract] [Full Text] [Related]

  • 29. Assessment of resistance to influenza virus infection in animal models.
    Potter CW, McLaren C, Jennings R.
    Dev Biol Stand; 1975 Nov 10; 28():307-18. PubMed ID: 1126574
    [Abstract] [Full Text] [Related]

  • 30. Transcutaneous immunization with inactivated influenza virus induces protective immune responses.
    Skountzou I, Quan FS, Jacob J, Compans RW, Kang SM.
    Vaccine; 2006 Aug 28; 24(35-36):6110-9. PubMed ID: 16766095
    [Abstract] [Full Text] [Related]

  • 31. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T, Watanabe I, Ito S, Fujii H, Moriyama M, Tamura S, Takahashi H, Sawa H, Chiba J, Kurata T, Sata T, Hasegawa H.
    J Virol; 2005 Mar 28; 79(5):2910-9. PubMed ID: 15709010
    [Abstract] [Full Text] [Related]

  • 32. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry.
    Worrall EE, Sudarisman, Priadi A.
    Vaccine; 2009 Jun 24; 27(31):4161-8. PubMed ID: 19406183
    [Abstract] [Full Text] [Related]

  • 33. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
    Ann J, Samant M, Rheaume C, Dumas C, Beaulieu E, Morasse A, Mallett C, Hamelin ME, Papadopoulou B, Boivin G.
    Vaccine; 2014 Sep 29; 32(43):5730-9. PubMed ID: 25173481
    [Abstract] [Full Text] [Related]

  • 34. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, Morag A, Zakay-Rones Z.
    J Med Virol; 2001 Sep 29; 65(1):178-84. PubMed ID: 11505461
    [Abstract] [Full Text] [Related]

  • 35. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.
    Microbiol Immunol; 2008 Feb 29; 52(2):55-63. PubMed ID: 18380802
    [Abstract] [Full Text] [Related]

  • 36. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.
    Del Giudice G, Hilbert AK, Bugarini R, Minutello A, Popova O, Toneatto D, Schoendorf I, Borkowski A, Rappuoli R, Podda A.
    Vaccine; 2006 Apr 12; 24(16):3063-5. PubMed ID: 16464520
    [Abstract] [Full Text] [Related]

  • 37. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice.
    Hovden AO, Cox RJ, Haaheim LR.
    Scand J Immunol; 2005 Jul 12; 62(1):36-44. PubMed ID: 16092921
    [Abstract] [Full Text] [Related]

  • 38. H9N2 influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice.
    Qin T, Yin Y, Huang L, Yu Q, Yang Q.
    Clin Vaccine Immunol; 2015 Apr 12; 22(4):421-9. PubMed ID: 25673304
    [Abstract] [Full Text] [Related]

  • 39. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.
    Vesikari T, Pellegrini M, Karvonen A, Groth N, Borkowski A, O'Hagan DT, Podda A.
    Pediatr Infect Dis J; 2009 Jul 12; 28(7):563-71. PubMed ID: 19561422
    [Abstract] [Full Text] [Related]

  • 40. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T, Watanabe I, Tao E, Ito S, Kawaguchi A, Tamura S, Takahashi H, Sawa H, Moriyama M, Chiba J, Komase K, Suzuki Y, Kurata T, Sata T, Hasegawa H.
    J Med Virol; 2006 Jul 12; 78(7):954-63. PubMed ID: 16721854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 73.